ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,072Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 546

$753K Total Retail Price of All Prescriptions

Rank: 17 out of 546

549 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 14,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
FUROSEMIDE 658 591 1 5
METOPROLOL TARTRATE 654 526 2 6
SERTRALINE HCL 632 538 3 14
LISINOPRIL 592 496 4 1
OMEPRAZOLE 516 408 5 4
HYDROCODONE-ACETAMINOPHEN 481 299 S3 6 8
LEVOTHYROXINE SODIUM 452 370 7 3
SIMVASTATIN 451 367 8 2
WARFARIN SODIUM 425 346 9 13
PANTOPRAZOLE SODIUM 335 276 10 18
TRAMADOL HCL 261 225 11 19
METFORMIN HCL 247 199 12 10
DONEPEZIL HCL 236 223 13 31
ATENOLOL 226 210 14 12
HYDROCHLOROTHIAZIDE 220 213 15 7
RISPERIDONE 208 179 16 47
PREDNISONE 206 179 17 29
TRAZODONE HCL 192 161 18 25
POTASSIUM CHLORIDE 179 147 19 30
AMLODIPINE BESYLATE 179 157 19 9
FENTANYL 174 166 S2 21 50
NAMENDA 169 169 22 60
METOPROLOL SUCCINATE 159 152 23 17
TAMSULOSIN HCL 157 157 24 35
GABAPENTIN 155 118 25 16
IPRATROPIUM-ALBUTEROL 153 153 26 90
ADVAIR DISKUS 143 114 27 20
GLIPIZIDE 137 101 28 44
LEVEMIR 134 134 29 124
CITALOPRAM HBR 128 116 30 21
OXYCODONE HCL 126 104 S2 31 15
ATORVASTATIN CALCIUM 122 117 32 11
RANITIDINE HCL 119 64 33 23
PROAIR HFA 119 70 33 27
ALLOPURINOL 117 116 35 41
METHENAMINE HIPPURATE 114 75 36 199
CRESTOR 110 64 37 36
TRIAMTERENE-HCTZ 107 81 38 89
TERAZOSIN HCL 102 101 39 83
LOVASTATIN 97 93 40 22
CYCLOBENZAPRINE HCL 96 36 R 41 34
CARBIDOPA-LEVODOPA 96 96 41 76
HALOPERIDOL 91 76 43 102
LANTUS 89 75 44 46
FLUOXETINE HCL 88 53 45 39
OXYBUTYNIN CHLORIDE 88 59 45 106
LOSARTAN POTASSIUM 87 77 47 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 82 48 104
LACTULOSE 86 77 48 96
NITROGLYCERIN PATCH 86 86 48 117
KLOR-CON M20 85 78 51 57
CIPROFLOXACIN HCL 85 76 51 84
ALENDRONATE SODIUM 83 69 53 38
NYSTATIN-TRIAMCINOLONE 82 79 54 160
MECLIZINE HCL 80 80 55 131
SPIRIVA 79 64 56 28
SUCRALFATE 76 69 57 137
OXYCODONE-ACETAMINOPHEN 73 48 S2 58 54
DIVALPROEX SODIUM 72 42 59 78
GEMFIBROZIL 72 58 59 100
TRIAMCINOLONE ACETONIDE 70 69 61 112
CEFTRIAXONE 69 69 62 184
QUETIAPINE FUMARATE 67 52 63 72
CYMBALTA 66 28 64 37
HYDRALAZINE HCL 66 54 64 140
CEPHALEXIN 66 58 64 111
AZITHROMYCIN 66 51 64 55
ALBUTEROL SULFATE 63 61 68 148
ACTONEL 62 50 69 163
PHENYTOIN SODIUM EXTENDED 61 49 70 225
JANTOVEN 60 60 71 92
LEVEMIR FLEXPEN 58 44 72 130
PROPRANOLOL HCL 56 47 73 99
NEXIUM 56 31 73 52
BACLOFEN 53 26 75 86
VENTOLIN HFA 53 34 75 63
ROPINIROLE HCL 52 52 77 64
LITHIUM CARBONATE 52 27 77 193
LIPITOR 51 45 79 80
ISOSORBIDE MONONITRATE ER 51 51 79 32
CARVEDILOL 51 47 79 56
TAMIFLU 50 44 82 172
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.